Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
06/30/2017 |
Director
Trans History: 145
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 369 | $40.14 | 45,614 |
06/30/2017 |
Director
Trans History: 145
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 369 | $40.14 | 45,614 |
06/30/2017 |
Director
Trans History: 92
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 369 | $40.14 | 24,736 |
08/1/2017 |
Director
Trans History: 175
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $40.14 | 36,608 |
08/1/2017 |
Director
Trans History: 207
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $40.14 | 34,521 |
12/5/2019 |
Director
Trans History: 9
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,484 | $40.16 | 46,755 |
06/1/2017 |
Director
Trans History: 175
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 41 | $40.23 | 36,162 |
06/1/2017 |
Director
Trans History: 207
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $40.23 | 34,009 |
12/9/2021 |
Senior Vice President
Trans History: 111
|
Senior Vice President | Form 4 | Open market or private sale of non-derivative or derivative security | 3,155 | $40.34 | 22,405 |
09/28/2018 |
Chief Risk Officer
Trans History: 120
|
Chief Risk Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7 | $40.37 | 15,560 |
Pagination
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.